FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
25,971,527
Share change
+1,567,013
Total reported value
$569,306,119
Put/Call ratio
345%
Price per share
$21.92
Number of holders
132
Value change
+$22,369,595
Number of buys
76
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q4 2017

As of 31 Dec 2017, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 132 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,971,527 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., DIMENSIONAL FUND ADVISORS LP, VICTORY CAPITAL MANAGEMENT INC, BB BIOTECH AG, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 132 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.